Ligand-based targeting is a sophisticated strategy employed in nanotechnology to enhance the specificity and efficacy of drug delivery systems. The approach involves conjugating ligands—molecules capable of binding to specific receptors—onto the surface of nanoparticles. These ligand-coated nanoparticles are designed to selectively bind to target cells or tissues, thereby improving the precision of therapeutic interventions.
